Stay updated on Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Page now shows Revision: v3.0.2, replacing the old v3.0.1; the 'Back to Top' element was removed.
    Difference
    0.2%
    Check dated 2025-09-13T17:39:05.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-06T15:18:16.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of a new facility name and location in St. Louis, Missouri, as well as the introduction of new medical topics related to cancer and immunotherapy. Notably, several previous topics and terms related to lung cancer and certain immunological agents have been removed.
    Difference
    5%
    Check dated 2025-08-30T11:56:18.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T04:34:46.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.10 to v2.16.11.
    Difference
    0.1%
    Check dated 2025-08-08T23:49:41.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    1.0%
    Check dated 2025-08-01T19:19:07.000Z thumbnail image

Stay in the know with updates to Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page.